PX
50
-12
TGNA
69
2
FAST
46
2
PM
66
2
LH
36
-4
DOV
59
2
PEG
55
4
D
37
5
V
54
4
CME
61
2
QRVO
9
4
A
43
2
ED
49
3
AN
35
3
CMG
50
2
WDC
25
-10
AON
75
4
HRL
42
3
NSC
50
10
MDT
55
3
PX
50
-12
TGNA
69
2
FAST
46
2
PM
66
2
LH
36
-4
DOV
59
2
PEG
55
4
D
37
5
V
54
4
CME
61
2
QRVO
9
4
A
43
2
ED
49
3
AN
35
3
CMG
50
2
WDC
25
-10
AON
75
4
HRL
42
3
NSC
50
10
MDT
55
3
Financhill
Back

INmune Bio 10K Form

Sell
37

INMB
INmune Bio

Last Price:
$7.61
Seasonality Move:
27.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INMB News And Ratings

See the #1 stock for the next 7 days that we like better than INMB

INMB Financial Statistics

Sales & Book Value

Annual Sales: $14K
Cash Flow: $-11M
Price / Cash Flow: 0
Annual Sales: $1.45
Price / Book: 5.52

Profitability

EPS (TTM): -2.11000
Net Income (TTM): $-42.1M
Gross Margin: --
Return on Equity: -79.18%
Return on Assets: -55.6%

INmune Bio Earnings Forecast

Key INmune Bio Financial Ratios

  • The Research & Development expenses have been 236,900.00% of Revenue.
  • The Net Earning history of INMB is -300,585.71% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 2 years.

INmune Bio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: INMB
CUSIP: 45782T
Website: inmunebio.com

Debt

Debt-to-Equity Ratio: 0.26
Current Ratio: 1.71
Quick Ratio: 1.64

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INMB Technical Analysis vs Fundamental Analysis

Sell
37
INmune Bio (INMB) is a Sell

Is INmune Bio a Buy or a Sell?

  • INmune Bio stock is rated a Sell
    The current INmune Bio [INMB] share price is $7.81. The Score for INMB is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.